US2019134125A1PendingUtilityA1

Enhanced smokable therapeutic cannabis product and method for making same

53
Assignee: CMG PARTNERS INCPriority: Jun 6, 2017Filed: Jan 7, 2019Published: May 9, 2019
Est. expiryJun 6, 2037(~10.8 yrs left)· nominal 20-yr term from priority
Inventors:Michael Viet Thang VuLarry Nelson Thacker, Jr.Nelson Miguel Ricardo MartinezAaron DuranSteven Stubblefield
A61K 36/3482A24D 1/18A24B 15/303A61K 2236/35A24B 15/241A61K 36/185A61K 2236/15A61K 2236/51A24B 15/16
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An enhanced smokable cannabis -based product produced by separating hash resin from plant material of the cannabis plant, pressing the hash resin to expel oil, leaving spent hash resin, extracting further cannabinoids from the spent hash resin using MCT oil, enriching the extracted oil with a formulation comprising at least purified β-myrcene, and spraying the enriched oil onto dried smokable cannabis plant matter.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of preparing an enhanced smokable therapeutic  cannabis  product, the method comprising the steps of:
 (a) separating hash resin from plant material of a  cannabis  plant;   (b) pressing the hash resin to expel oil, leaving spent hash resin;   (c) extracting further cannabinoids from the spent hash resin using medium chain triglyceride oil;   (d) enriching the extracted oil with a formulation comprising at least purified  13 -myrcene; and   (e) spraying the enriched oil onto dried smokable  cannabis  plant matter; wherein the formulation comprises at least 5% w/w β-myrcene, between 10% w/w and 20% w/w cannabinol (CBN), and at least 5% w/w pinene   
     
     
         2 . The method of  claim 1 , further comprising the step of wrapping the dried smokable plant matter into a conical smokable product after spraying. 
     
     
         3 . The method of  claim 1 , wherein the formulation comprises at least 25% by weight of purified THC. 
     
     
         4 . The method of  claim 1 , wherein the formulation comprises at least 25% by weight of purified CBD. 
     
     
         5 . The method of  claim 1 , wherein the formulation comprises at least 25% by weight of purified THC and 25% by weight of purified CBD. 
     
     
         6 . A smokable therapeutic  cannabis -based product produced according to the method of  claim 1 . 
     
     
         7 . A smokable therapeutic  cannabis -based product produced according to the method of  claim 2 . 
     
     
         8 . A smokable therapeutic  cannabis -based product produced according to the method of  claim 3 . 
     
     
         9 . A smokable therapeutic  cannabis -based product produced according to the method of  claim 4 . 
     
     
         10 . A smokable therapeutic  cannabis -based product produced according to the method of  claim 5 .

Join the waitlist — get patent alerts

Track US2019134125A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.